A Study to Explore Signs, Symptoms, and Biomarkers in Dry Eye Disease Participants Following Anti-inflammatory Treatment

Clinical trial NCT07025811 · COMPLETED

Trial details

NCT number: NCT07025811
Sponsor: Hoffmann-La Roche
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Dry Eye Disease

Start date: 2025-07-09
Primary completion: 2026-07-16
Enrollment: 378

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.